|
GB9203689D0
(en)
*
|
1992-02-20 |
1992-04-08 |
Euro Celtique Sa |
Pharmaceutical composition
|
|
GB9310030D0
(en)
*
|
1993-05-15 |
1993-06-30 |
Scras |
Dry processed particles and process for the preparation of the same
|
|
GB9505032D0
(en)
*
|
1995-03-13 |
1995-05-03 |
Westminster Lab Ltd |
Improvements in or relating to organic compositions
|
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
|
US5965161A
(en)
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
|
JPH11514382A
(en)
*
|
1995-11-02 |
1999-12-07 |
メルク フロスト カナダ アンド カンパニー |
New wet granulation method
|
|
WO1998025590A2
(en)
*
|
1996-12-12 |
1998-06-18 |
Dds Drug Delivery Service Gesellschaft Zur Förderung Der Forschung In Pharmazeutischer Technologie Und Biopharmazie Mbh |
Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance
|
|
US5980882A
(en)
*
|
1997-04-16 |
1999-11-09 |
Medeva Pharmaceuticals Manufacturing |
Drug-resin complexes stabilized by chelating agents
|
|
US5916595A
(en)
*
|
1997-12-12 |
1999-06-29 |
Andrx Pharmaceutials, Inc. |
HMG co-reductase inhibitor
|
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
|
US8679534B2
(en)
*
|
1997-12-12 |
2014-03-25 |
Andrx Labs, Llc |
HMG-CoA reductase inhibitor extended release formulation
|
|
IT1298574B1
(en)
*
|
1998-02-06 |
2000-01-12 |
Vectorpharma Int |
PHARMACEUTICAL COMPOSITIONS IN THE FORM OF POLYMER-BASED MICROPARTICLES OBTAINED BY EXTRUSION AND SPHERONIZATION
|
|
US7122207B2
(en)
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
|
UA69413C2
(en)
|
1998-05-22 |
2004-09-15 |
Брістол-Майерс Сквібб Компані |
Enteric coated pharmaceutical composition, pharmaceutical composition in form of spheroid beads, method for manufacturing pharmaceutical composition
|
|
UA73092C2
(en)
|
1998-07-17 |
2005-06-15 |
Брістол-Майерс Сквібб Компані |
Tablets with enteric coating and method for their manufacture
|
|
DE19855440A1
(en)
*
|
1998-12-01 |
2000-06-08 |
Basf Ag |
Process for the production of solid dosage forms by melt extrusion
|
|
DE19918325A1
(en)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
|
|
JP2003522127A
(en)
*
|
1999-07-29 |
2003-07-22 |
ロクセニ ラボラトリーズ インコーポレイテッド |
Opioid sustained release formulation
|
|
US6555551B1
(en)
|
1999-08-31 |
2003-04-29 |
Mutual Pharmaceutical Co., Inc. |
Stable formulations of ACE inhibitors, and methods for preparation thereof
|
|
US20030225124A1
(en)
*
|
1999-08-31 |
2003-12-04 |
Spiridon Spireas |
Stable formulations of ACE inhibitors, and methods for preparation thereof
|
|
US6764694B1
(en)
*
|
1999-08-31 |
2004-07-20 |
Mutual Pharmaceutical Co., Inc. |
Stable formulations of ACE inhibitors, and methods for preparation thereof
|
|
US20040157911A1
(en)
*
|
1999-08-31 |
2004-08-12 |
Spiridon Spireas |
Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
|
|
DE10008506A1
(en)
*
|
2000-02-24 |
2001-09-13 |
Bayer Ag |
Process for the preparation of pharmaceutical dosage forms
|
|
USRE44578E1
(en)
|
2000-04-10 |
2013-11-05 |
Teva Pharmaceutical Industries, Ltd. |
Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
|
|
DK2382970T3
(en)
*
|
2000-04-10 |
2013-03-25 |
Teva Pharma |
STABLE PHARMACEUTICAL COMPOSITIONS CONTAINING 7-SUBSTITUTED-3,5-DIHYDROXYHEPTANIC ACIDS OR 7-SUBSTITUTED-3,5-DIHYDROXYHEPHENIC ACIDS
|
|
CA2542968C
(en)
*
|
2003-10-20 |
2013-06-04 |
Framework Therapeutics, L.L.C. |
Zeolite molecular sieves for the removal of toxins
|
|
US7387793B2
(en)
*
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
|
DE102005042875A1
(en)
*
|
2004-12-23 |
2006-09-21 |
Grünenthal GmbH |
Fast-release dosage forms for antibiotics
|
|
US8318230B2
(en)
*
|
2005-05-02 |
2012-11-27 |
Henkel Ag & Co. Kgaa |
Use of debranched starch in extrusion-spheronization pharmaceutical pellets
|
|
CA2578626C
(en)
|
2005-06-27 |
2011-07-19 |
Biovail Laboratories International S.R.L. |
Modified-release formulations of a bupropion salt
|
|
US20090246276A1
(en)
|
2008-01-28 |
2009-10-01 |
Graham Jackson |
Pharmaceutical Compositions
|
|
BRPI0918499A2
(en)
*
|
2008-09-02 |
2015-12-01 |
Usv Ltd |
cross-linked polymers
|
|
WO2012042314A1
(en)
|
2010-10-02 |
2012-04-05 |
Link Research & Grants Corporation |
Treatment of tinnitus and related auditory dysfunctions
|
|
WO2012064266A1
(en)
|
2010-11-04 |
2012-05-18 |
Albireo Ab |
Ibat inhibitors for the treatment of liver diseases
|
|
US20120308895A1
(en)
|
2011-05-31 |
2012-12-06 |
General Electric Company |
Electrode compositions useful for energy storage devices and other applications; and related devices and processes
|
|
CN106659726A
(en)
|
2014-06-25 |
2017-05-10 |
Ea制药株式会社 |
Solid preparation, and method for preventing or reducing discoloration thereof
|
|
EP3012252A1
(en)
|
2014-10-24 |
2016-04-27 |
Ferring BV |
Crystal modifications of elobixibat
|
|
US10441604B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Cholestyramine pellets and methods for preparation thereof
|
|
US10441605B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
ES2784446T3
(en)
*
|
2016-02-09 |
2020-09-25 |
Albireo Ab |
Cholestyramine microgranules and methods for their preparation
|
|
US10786529B2
(en)
|
2016-02-09 |
2020-09-29 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
WO2019032027A1
(en)
*
|
2017-08-09 |
2019-02-14 |
Albireo Ab |
Cholestyramine pellets, oral cholestyramine formulations and use thereof
|
|
JP2020530448A
(en)
|
2017-08-09 |
2020-10-22 |
アルビレオ・アクチボラグ |
Cholestyramine granules, oral cholestyramine preparations, and their use
|
|
CN107552777A
(en)
*
|
2017-09-05 |
2018-01-09 |
昆山玛冀电子有限公司 |
A kind of powder particle composition and production technology for inductance production
|
|
AU2018360383A1
(en)
|
2017-11-02 |
2020-05-21 |
Natureceuticals Sdn. Bhd. |
Extract of orthosiphon stamineus, formulations, and uses thereof
|
|
TW202015699A
(en)
|
2018-06-05 |
2020-05-01 |
瑞典商艾爾比瑞歐公司 |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
US10793534B2
(en)
|
2018-06-05 |
2020-10-06 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
HUE070725T2
(en)
|
2018-06-20 |
2025-06-28 |
Albireo Ab |
Crystal modifications of odevixibat
|
|
US11801226B2
(en)
|
2018-06-20 |
2023-10-31 |
Albireo Ab |
Pharmaceutical formulation of odevixibat
|
|
US11549878B2
(en)
|
2018-08-09 |
2023-01-10 |
Albireo Ab |
In vitro method for determining the adsorbing capacity of an insoluble adsorbant
|
|
US11007142B2
(en)
|
2018-08-09 |
2021-05-18 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10722457B2
(en)
|
2018-08-09 |
2020-07-28 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10941127B2
(en)
|
2019-02-06 |
2021-03-09 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
|
US10975045B2
(en)
|
2019-02-06 |
2021-04-13 |
Aibireo AB |
Benzothiazepine compounds and their use as bile acid modulators
|
|
CA3127568A1
(en)
|
2019-02-06 |
2020-08-13 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
|
JP7665620B2
(en)
|
2019-12-04 |
2025-04-21 |
アルビレオ・アクチボラグ |
Benzothiadiazepine compounds and their use as bile acid modulators - Patents.com
|
|
US11014898B1
(en)
|
2020-12-04 |
2021-05-25 |
Albireo Ab |
Benzothiazepine compounds and their use as bile acid modulators
|
|
AU2020397448A1
(en)
|
2019-12-04 |
2022-05-26 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
JP7696898B2
(en)
|
2019-12-04 |
2025-06-23 |
アルビレオ・アクチボラグ |
Benzothia(di)azepine compounds and their use as bile acid modulators - Patents.com
|
|
CN114761080B
(en)
|
2019-12-04 |
2024-07-23 |
阿尔比里奥公司 |
Benzothia(di)azepine compounds and their use as bile acid regulators
|
|
CA3186857A1
(en)
|
2020-08-03 |
2022-02-10 |
Per-Goran Gillberg |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
EP4243831A1
(en)
|
2020-11-12 |
2023-09-20 |
Albireo AB |
Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
|
|
CN116583504A
(en)
|
2020-12-04 |
2023-08-11 |
阿尔比里奥公司 |
Benzothiazepine compounds and their use as bile acid modulators
|